These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 5523876
21. [Study of the hypouricemic effect of benziodarone in chronic renal insufficiency]. Ponticelli C, Locatelli F, Graziani G. Arch Ital Urol Nefrol; 1967; 40(6):461-75. PubMed ID: 5607121 [No Abstract] [Full Text] [Related]
22. Uricosuric effect of benziodarone in man and laboratory animals: a comparative study. Lemieux G, Gougoux A, Vinay P, Michaud G. Am J Physiol; 1973 Jun; 224(6):1431-9. PubMed ID: 4197184 [No Abstract] [Full Text] [Related]
23. Effect of drugs on the renal handling of urate. Emmerson BT. Prog Biochem Pharmacol; 1974 Jun; 9():142-52. PubMed ID: 4438376 [No Abstract] [Full Text] [Related]
24. [Clinical and biochemical study of a new uricosuric: benziodarone]. Rapado A, Llamazares C. Rev Esp Reum Enferm Osteoartic; 1968 Oct; 12(8):249-51. PubMed ID: 5736091 [No Abstract] [Full Text] [Related]
25. Uricosuric potency of 2-substituted analogs of probenecid. Blanchard KC, Maroske D, May DG, Weiner IM. J Pharmacol Exp Ther; 1972 Feb; 180(2):397-410. PubMed ID: 4622053 [No Abstract] [Full Text] [Related]
26. Studies with some novel uricosuric agents and their metabolites: correlation between clinical activity and drug-induced displacement of urate from its albumin-binding sites. Schlosstein LH, Kippen I, Whitehouse MW, Bluestone R, Paulus HE, Klinenberg JR. J Lab Clin Med; 1973 Sep; 82(3):412-8. PubMed ID: 4740876 [No Abstract] [Full Text] [Related]
27. [Effect of transtubular transport inhibitors in the renal excretion of uric acid in the rat]. Boudry JF. Pflugers Arch; 1971 Sep; 328(4):279-91. PubMed ID: 5107270 [No Abstract] [Full Text] [Related]
28. [Comparative study of the hypouricemic effects of calcitonin and sulfinpyrazone]. Rico Lenza H, Huertas García-Alejo R, del Río Vázquez A, Espinós Pérez D. Rev Clin Esp; 1982 Feb 28; 164(4):249-52. PubMed ID: 6283606 [No Abstract] [Full Text] [Related]
29. [Clinical and biological action of a new hypouricemiant (benziodarone) in gout. Results of 2 years of experience]. Santamaría A, Barceló P. Rev Esp Reum Enferm Osteoartic; 1968 Oct 28; 12(8):252-63. PubMed ID: 4899417 [No Abstract] [Full Text] [Related]
30. [Anuria due to bilateral ureteral uric acid lithiasis during a treatment with Amplivix]. Navas P, Grasset D. J Urol Nephrol (Paris); 1973 Dec 28; 79(12 Pt 2):466-9. PubMed ID: 4804419 [No Abstract] [Full Text] [Related]
32. [On clinical experiences with 2-ethyl-3(4-hydroxy-3,5-dibrombenzoyl)-benzofuran ("Benzbromaron") in the therapy of gout and hyperuricemia]. Kotzaurek R, Hueber EF. Wien Med Wochenschr; 1968 Nov 23; 118(47):1014-8. PubMed ID: 5704263 [No Abstract] [Full Text] [Related]
33. Pharmacology of pyrazinamide: metabolic and renal function studies related to the mechanism of drug-induced urate retention. Weiner IM, Tinker JP. J Pharmacol Exp Ther; 1972 Feb 23; 180(2):411-34. PubMed ID: 4622054 [No Abstract] [Full Text] [Related]
35. Management of gout and hyperuricemia. Wisner DE, Simkin PA. Prim Care; 1984 Jun 23; 11(2):283-94. PubMed ID: 6206519 [Abstract] [Full Text] [Related]
38. [Diagnosis and therapy of gout and hyperuricemia]. Guzmán L. Rev Med Chil; 1981 Dec 23; 109(12):1191-7. PubMed ID: 7346920 [No Abstract] [Full Text] [Related]
40. [Study of the effects of benziodarone in 100 gouty patients during a diuresis cure: effects on uric acid and oxalic acid]. Mugler A. Rein Foie; 1967 Dec 23; 10():273-92. PubMed ID: 6081455 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]